CDMO0.00%14.3%
CRL+82.40%14.3%
DGX+35.60%14.3%
FTRE+120.64%14.3%
LH+20.91%14.3%
MRVI+252.65%14.3%
NOTV0.00%14.3%
As of Aug 24, 2026, 4:53 AM ET
MedTech Long '24: Lab Research & Trials Constituents
Avid Bioservices, Inc.CDMO | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $361.4M |
Charles River Laboratories International, Inc.CRL | 14.3% | 1.28% | 4.68% | 30.28% | 26.96% | 47.98% | 65.38% | 97.74% | 43.81% | -30.68% | 82.40% | $14.22B |
Fortrea Holdings Inc.FTRE | 14.3% | 1.10% | -5.79% | -5.79% | -4.07% | 6.61% | 71.55% | 144.87% | -16.52% | -38.90% | 120.64% | $1.75B |
Inotiv, Inc.NOTV | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -39.50% | 0.00% | $553.0M |
Labcorp Holdings Inc.LH | 14.3% | 1.06% | 4.32% | 13.33% | 8.78% | 34.06% | 16.33% | 42.29% | 46.56% | 33.47% | 20.91% | $27.58B |
Maravai LifeSciences Holdings, Inc.MRVI | 14.3% | 4.22% | 48.71% | 27.81% | 31.51% | 165.85% | 142.70% | 290.95% | -3.03% | -85.51% | 252.65% | $2.39B |
Quest Diagnostics IncorporatedDGX | 14.3% | 1.28% | 2.90% | 7.25% | 4.88% | 40.83% | 15.33% | 46.22% | 60.72% | 75.02% | 35.60% | $26.97B |
| Theme return | — | 1.28% | 7.83% | 13.52% | 9.06% | 39.35% | 40.66% | 88.43% | 37.04% | 1.18% | 69.90% | — |
| Average | 14.3% | 1.28% | 7.83% | 10.41% | 9.72% | 42.19% | 44.47% | 88.87% | 18.79% | -12.30% | 73.17% | $10.55B |
| Median | 14.3% | 1.10% | 2.90% | 7.25% | 4.88% | 34.06% | 16.33% | 46.22% | 0.00% | -30.68% | 35.60% | $2.39B |
| Std Dev | 0.0% | 1.31% | 17.01% | 13.07% | 12.96% | 53.74% | 48.43% | 95.50% | 28.25% | 49.30% | 84.01% | $11.47B |
| Min | 14.3% | 0.00% | -5.79% | -5.79% | -4.07% | 0.00% | 0.00% | 0.00% | -16.52% | -85.51% | 0.00% | $361.4M |
| Max | 14.3% | 4.22% | 48.71% | 30.28% | 31.51% | 165.85% | 142.70% | 290.95% | 60.72% | 75.02% | 252.65% | $27.58B |
| % Positive Tickers | 71.43% | 57.14% | 57.14% | 57.14% | 71.43% | 71.43% | 71.43% | 42.86% | 28.57% | 71.43% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
MedTech Long '24: Lab Research & Trials tracks 7 publicly listed stocks in this theme: CDMO, CRL, DGX, FTRE, LH, MRVI, NOTV. See the constituent table for details.